Skip to content
Screener

Neuropace, Inc. NPCE Cash Flow Statement

Q2 '26Q1 '26Q4 '25Q3 '25Q2 '25
-$6.2M+28.3%-$6.69M-1.5%-$2.73M+48.0%-$3.5M+35.9%-$8.65M-15.1%
$100K0.0%$60K+22.4%$80K+66.7%$100K0.0%$100K0.0%
$2.3M-28.7%$2.28M-13.3%$2.61M+0.2%$2.63M+1.4%$3.23M+26.7%
-$3.9M-87.1%-$5.9M+21.1%$0+100%-$1.94M-12.8%-$2.09M+46.5%
$125K-25.6%$117K+216%$97K+149%$30K-70.0%$168K+167%
-$125K+25.6%-$117K-216%-$97K-105%-$30K-102%-$168K-105%
$0$0-100%
$1.18M-$166K-101%$635K-25.1%
-$2.85M-$6.18M-146%$1.04M+153%
-$4.03M-78.7%-$6.02M+20.0%$0+100%-$1.97M-8.2%-$2.25M+43.1%

FAQ

How much cash does Neuropace, Inc. generate?
Neuropace, Inc. (NPCE) generated -$11.7M in operating cash flow over the trailing twelve months.
What is Neuropace, Inc.'s free cash flow?
After $369.0K of capital expenditures, Neuropace, Inc.'s free cash flow was -$12.0M over the trailing twelve months, up 26.9% year over year.
Where does Neuropace, Inc.'s cash flow data come from?
Every line is extracted from Neuropace, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.